Wednesday, September 2, 2026

2:15 PM - 3:45 PM

---

Details

Organised by the FIP Community Pharmacy Section Chair(s) Ms Rafa Al Khalifa, Universitat Pompeu Fabra, UAE, and Ms Lynnae Mahaney, Specia, USA Introduction: Specialty medications — used to treat complex conditions such as cancer, autoimmune diseases, multiple sclerosis, hepatitis, and HIV—require dedicated clinical expertise and specialised pharmacy models. These therapies are high-cost, involve intensive monitoring, and demand operational systems that often vary significantly by region. This panel will feature specialty pharmacy leaders from Canada, the UAE and the USA. Together, they will share global perspectives on specialty pharmacy practices, including clinical management, operational structures, quality standards, and patient care models unique to their regions. Attendees will gain practical insights, real-world strategies, and cross-regional comparisons to support strengthening specialty pharmacy programmes and optimising patient outcomes. Panelists will respond to targeted questions in each category, offering actionable recommendations and lessons learned from their respective health systems. Programme: Panellists: Dr. Jill Paslier, Specia, USA Dr. Idan Reichhardt, Sanavie, Canada Ms Brigitte Viel, Regroupement des pharmacies de médicaments de spécialité du Québec (RPMSQ), Canada Learning objectives: 1. Explore the clinical, operational, and quality considerations for specialty pharmacy models across regions. 2. Learn actionable strategies for implementing or improving specialty pharmacy services within community or outpatient settings. 3. Gain insights into how global best practices can be adapted to improve patient care and streamline workflows. Take home messages: This session provides a unique opportunity to hear directly from international specialty pharmacy experts, offering practical tools, actionable recommendations, and cross-regional insights. By learning from global experiences, pharmacists can strengthen specialty pharmacy programmes and improve patient outcomes in their own settings. FIP Development Goals: To learn more about these FIP Development Goals, click on the links below. FIP Development Goal 7: Advancing Integrated Services FIP Development Goal 11: Impact and Outcomes FIP Development Goal 15: People-Centred Care

---

Chairs & speakers